Whittier Trust CO Of Nevada Inc Amgen Inc Transaction History

Whittier Trust CO Of Nevada Inc

  • $4.34 Billion
  • Q2 2025

A detailed history of Whittier Trust CO Of Nevada Inc transactions in Amgen Inc stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 22,348 shares of AMGN stock, worth $6.61 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
22,348
Previous 22,310 0.17%
Holding current value
$6.61 Million
Previous $6.95 Million 10.23%
% of portfolio
0.14%
Previous 0.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025
BUY
$262.28 - $309.85 $9,966 - $11,774
38 Added 0.17%
22,348 $6.24 Million
Q1 2025

May 02, 2025
BUY
$258.59 - $327.36 $92,316 - $116,867
357 Added 1.63%
22,310 $6.95 Million
Q4 2024

Feb 11, 2025
BUY
$258.78 - $328.31 $59,001 - $74,854
228 Added 1.05%
21,953 $5.72 Million
Q3 2024

Oct 21, 2024
BUY
$309.38 - $337.38 $614,428 - $670,036
1,986 Added 10.06%
21,725 $7 Million
Q2 2024

Jul 26, 2024
SELL
$262.75 - $319.31 $228,067 - $277,161
-868 Reduced 4.21%
19,739 $6.17 Million
Q1 2024

May 02, 2024
BUY
$268.87 - $324.56 $171,001 - $206,420
636 Added 3.18%
20,607 $5.86 Million
Q4 2023

Jan 11, 2024
BUY
$255.7 - $288.46 $256,211 - $289,036
1,002 Added 5.28%
19,971 $5.75 Million
Q3 2023

Oct 27, 2023
SELL
$218.65 - $271.46 $7,434 - $9,229
-34 Reduced 0.18%
18,969 $5.1 Million
Q2 2023

Jul 24, 2023
BUY
$214.27 - $253.37 $83,136 - $98,307
388 Added 2.08%
19,003 $4.22 Million
Q1 2023

Apr 21, 2023
SELL
$225.79 - $275.2 $288,559 - $351,705
-1,278 Reduced 6.42%
18,615 $4.5 Million
Q4 2022

Jan 25, 2023
SELL
$229.03 - $291.01 $11,680 - $14,841
-51 Reduced 0.26%
19,893 $0
Q3 2022

Oct 21, 2022
SELL
$224.46 - $253.15 $39,953 - $45,060
-178 Reduced 0.88%
19,944 $4.5 Million
Q2 2022

Jul 28, 2022
BUY
$230.71 - $256.74 $8,997 - $10,012
39 Added 0.19%
20,122 $4.9 Million
Q1 2022

Apr 29, 2022
BUY
$219.27 - $242.57 $1,973 - $2,183
9 Added 0.04%
20,083 $4.86 Million
Q4 2021

Jan 19, 2022
SELL
$198.88 - $227.6 $72,790 - $83,301
-366 Reduced 1.79%
20,074 $4.52 Million
Q3 2021

Nov 01, 2021
SELL
$212.27 - $248.7 $2,971 - $3,481
-14 Reduced 0.07%
20,440 $4.35 Million
Q2 2021

Jul 29, 2021
BUY
$233.58 - $259.14 $378,633 - $420,065
1,621 Added 8.61%
20,454 $4.99 Million
Q1 2021

Apr 26, 2021
BUY
$221.91 - $258.6 $1.06 Million - $1.23 Million
4,758 Added 33.8%
18,833 $4.69 Million
Q4 2020

Jan 29, 2021
BUY
$216.38 - $257.67 $375,852 - $447,572
1,737 Added 14.08%
14,075 $3.24 Million
Q3 2020

Oct 30, 2020
SELL
$234.65 - $260.95 $164,020 - $182,404
-699 Reduced 5.36%
12,338 $3.14 Million
Q2 2020

Jul 10, 2020
BUY
$197.81 - $242.74 $62,705 - $76,948
317 Added 2.49%
13,037 $3.08 Million
Q1 2020

Apr 27, 2020
BUY
$182.24 - $241.7 $76,176 - $101,030
418 Added 3.4%
12,720 $2.58 Million
Q4 2019

Jan 31, 2020
BUY
$189.21 - $243.2 $14,569 - $18,726
77 Added 0.63%
12,302 $2.97 Million
Q3 2019

Oct 18, 2019
BUY
$174.11 - $208.62 $39,174 - $46,939
225 Added 1.88%
12,225 $2.37 Million
Q1 2019

Apr 29, 2019
SELL
$180.87 - $203.88 $27,130 - $30,582
-150 Reduced 1.23%
12,000 $2.28 Million
Q4 2018

Feb 07, 2019
BUY
$178.4 - $208.25 $25,511 - $29,779
143 Added 1.19%
12,150 $2.37 Million
Q2 2018

Jul 27, 2018
SELL
$166.05 - $186.51 $78,707 - $88,405
-474 Reduced 3.8%
12,007 $2.22 Million
Q2 2018

Jul 20, 2018
BUY
$166.05 - $186.51 $51,807 - $58,191
312 Added 2.56%
12,481 $1.48 Million
Q1 2018

May 01, 2018
BUY
$169.43 - $198.0 $31,344 - $36,630
185 Added 1.54%
12,169 $2.07 Million
Q4 2017

Feb 07, 2018
BUY
$168.79 - $188.59 $28,525 - $31,871
169 Added 1.43%
11,984 $2.08 Million
Q3 2017

Oct 23, 2017
BUY
$167.29 - $191.0 $1.98 Million - $2.26 Million
11,815
11,815 $2.2 Million

Others Institutions Holding AMGN

# of Institutions
3,281
Shares Held
441M
Call Options Held
6.14M
Put Options Held
7.25M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email